What is Agragene?
Agragene is at the forefront of agricultural innovation, utilizing advanced CRISPR-based genome engineering to develop eco-friendly biological crop pest control solutions. The company's technology is designed to create products applicable to thousands of insect pests worldwide, with an initial focus on the major global crop pest, spotted wing drosophila. Founded in 2017 and headquartered in St. Louis, Missouri, Agragene is strategically positioned to address critical needs in modern agriculture by offering sustainable alternatives to traditional chemical pesticides. Its dual approach of pursuing commercial product launch in the United States and an aggressive licensing strategy globally underscores its ambition for widespread market impact.
How much funding has Agragene raised?
Agragene has raised a total of $7.2M across 2 funding rounds:
Angel/Seed
$1.2M
Series A
$6M
Angel/Seed (2020): $1.2M with participation from Ospraie Management , LLC
Series A (2023): $6M led by Ospraie Ag Science and BioGenerator
Key Investors in Agragene
Ospraie Management , LLC
Ospraie Management, LLC is an investment firm that has provided early-stage backing to Agragene, indicating a focus on supporting innovative agricultural technology companies.
Ospraie Ag Science
Ospraie Ag Science, a key investor in Agragene's Series A round, likely specializes in venture capital for agricultural science and technology, supporting companies with disruptive innovations.
BioGenerator
BioGenerator, based in St. Louis, Missouri, is an organization focused on creating and growing innovative companies, providing both investment and comprehensive startup support, aligning with Agragene's growth objectives.
What's next for Agragene?
The recent major strategic investment of $6M is poised to accelerate Agragene's growth trajectory. This capital infusion is expected to fuel the company's commercial launch efforts in the US, expand its research and development pipeline, and significantly bolster its worldwide licensing initiatives. Agragene's commitment to sustainable agricultural practices and its proprietary CRISPR technology position it for substantial expansion and market leadership in the rapidly evolving agricultural technology sector. The company's strategic focus on high-impact pests and its robust market penetration strategy indicate a strong potential for future success and disruption within the pest control industry.
See full Agragene company page
